PharmEasy Report Finds Half of Tested Indians Have High or Irregular Blood Sugar

Overview

• Drawing on about four million diagnostic reports from its platform between 2021 and 2025, PharmEasy reports that roughly one in two tested individuals showed elevated or irregular blood sugar.
• HbA1c findings placed one in three results in the diabetic range and one in four in the prediabetic range, signaling a substantial burden among those tested.
• Elevated glucose increasingly appears in younger adults and peaks after age 60, with a gender gap showing 51.9% of men and 45.43% of women testing high.
• More than 90% of people with high sugar also had abnormal lipid, thyroid, liver or kidney markers, while nearly 60% of tests indicated insulin resistance.
• Platform signals show diabetes medicines rising from 25% of orders in 2021 to 34% in 2024, and those who retested within six months saw a 22% improvement in sugar control.